Literature DB >> 6712717

A comparison of the interaction of anthelmintic benzimidazoles with tubulin isolated from mammalian tissue and the parasitic nematode Ascaridia galli.

P J Dawson, W E Gutteridge, K Gull.   

Abstract

Colchicine and a range of anthelmintic benzimidazoles inhibited the in vitro polymerization of tubulin purified from the parasitic nematode Ascaridia galli. In most cases, this inhibition was more pronounced than that detected when these drugs were incubated with tubulin purified from mammalian tissue. In particular, oxfendazole and thiabendazole had virtually no effect on mammalian tubulin assembly whereas they were both good inhibitors of nematode tubulin polymerization. Electron microscopic examinations revealed no morphological differences between microtubules from either nematode or mammalian tissues polymerized in the presence or absence of drug, though the length and number of microtubules was reduced in the drug-incubated samples. These results show that the benzimidazole group of anthelmintics interacts specifically with nematode tubulin and that their selectivity, at least in part, is a direct consequence of such interaction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712717     DOI: 10.1016/0006-2952(84)90515-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies.

Authors:  Qiwen Duan; Yanfeng Liu; Carmen J Booth; Sara Rockwell
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

2.  Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses.

Authors:  Thanh Bach; Daryl J Murry; Larissa V Stebounova; Gregory Deye; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.

Authors:  Christopher Ma; Johnson Tran; Frank Gu; Roxanna Ochoa; Catherine Li; David Sept; Karl Werbovetz; Naomi Morrissette
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

4.  Exacerbation of acetaminophen hepatotoxicity by the anthelmentic drug fenbendazole.

Authors:  Carol R Gardner; Vladimir Mishin; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2011-11-01       Impact factor: 4.849

5.  Interaction of Colchicine-Site Ligands With the Blood Cell-Specific Isotype of β-Tubulin-Notable Affinity for Benzimidazoles.

Authors:  Felipe Montecinos; Maura Loew; Tak I Chio; Susan L Bane; Dan L Sackett
Journal:  Front Cell Dev Biol       Date:  2022-05-31

6.  Discovery of new vascular disrupting agents based on evolutionarily conserved drug action, pesticide resistance mutations, and humanized yeast.

Authors:  Riddhiman K Garge; Hye Ji Cha; Chanjae Lee; Jimmy D Gollihar; Aashiq H Kachroo; John B Wallingford; Edward M Marcotte
Journal:  Genetics       Date:  2021-08-26       Impact factor: 4.402

7.  Inhibitors of tubulin assembly identified through screening a compound library.

Authors:  Rachel E Morgan; Sunnoo Ahn; Sandra Nzimiro; Jean Fotie; Mitch A Phelps; Jeffrey Cotrill; Adam J Yakovich; Dan L Sackett; James T Dalton; Karl A Werbovetz
Journal:  Chem Biol Drug Des       Date:  2008-12       Impact factor: 2.817

8.  Fenbendazole as a potential anticancer drug.

Authors:  Qiwen Duan; Yanfeng Liu; Sara Rockwell
Journal:  Anticancer Res       Date:  2013-02       Impact factor: 2.480

9.  Identification of selective tubulin inhibitors as potential anti-trypanosomal agents.

Authors:  Rati Lama; Ranjodh Sandhu; Bo Zhong; Bibo Li; Bin Su
Journal:  Bioorg Med Chem Lett       Date:  2012-07-14       Impact factor: 2.823

10.  Optimization and Pharmacokinetic Evaluation of Synergistic Fenbendazole and Rapamycin Co-Encapsulated in Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles.

Authors:  Hee Ji Shin; Min Jeong Jo; Ik Sup Jin; Chun-Woong Park; Jin-Seok Kim; Dae Hwan Shin
Journal:  Int J Nanomedicine       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.